American Well Corporation (AMWL) (AMWL) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

American Well Corporation (AMWL) (AMWL) Healthcare & Pipeline Overview

American Well Corporation (AMWL) delivers telehealth solutions, providing urgent care, scheduled visits, and specialized medical services. With a focus on digital healthcare delivery, AMWL's platform and telemedicine equipment cater to diverse healthcare needs, positioning it within the evolving healthcare information services sector amidst growing demand for remote care.

What Is the Investment Thesis for AMWL?

American Well Corporation (AMWL) presents a complex investment thesis. The company operates in the growing telehealth market, but its profitability remains a concern, as reflected in its negative P/E ratio of -3.09 and a profit margin of -37.0%. While the company's gross margin of 49.7% indicates potential, its negative free cash flow of $-0.01B raises questions about its financial sustainability. Key growth catalysts include expanding telehealth adoption and strategic partnerships. However, risks include increasing competition and the need to achieve profitability. Investors should closely monitor AMWL's ability to improve its financial performance and capitalize on market opportunities.

Based on FMP financials and quantitative analysis

AMWL Key Highlights

Market Cap of $202M reflects its position as a smaller player in the telehealth market.

• P/E Ratio of -3.09 indicates the company is currently unprofitable.
• Profit Margin of -37.0% highlights the challenges in achieving profitability.
• Gross Margin of 49.7% suggests potential for profitability with improved cost management.
• Free Cash Flow of $-0.01B indicates the company is burning cash and needs to improve its cash flow management.

Who Are AMWL's Competitors?

AMWL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMWL's Key Strengths?

Comprehensive telehealth platform.

• Wide range of services.
• Established partnerships with healthcare providers.
• Experienced management team.

What Are AMWL's Weaknesses?

Lack of profitability.

• Negative free cash flow.
• High operating expenses.
• Intense competition.

What Could Drive AMWL Stock Higher?

Expansion of telehealth services into new specialties and geographic regions.

• Strategic partnerships with healthcare providers and payers.
• Potential regulatory changes that support telehealth adoption.
• Integration of AI and machine learning technologies into the platform.

What Are the Key Risks for AMWL?

Financial-distress signal — its Altman Z-Score of -7.09 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-35.1%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Increasing competition from established and emerging telehealth providers.
• Regulatory changes that could limit telehealth reimbursement.
• Cybersecurity threats and data privacy concerns.
• Challenges in achieving profitability and managing cash flow.

What Are the Growth Opportunities for AMWL?

• Expansion of Telehealth Services: AMWL can capitalize on the growing demand for telehealth by expanding its service offerings to include more specialized medical fields such as cardiology, oncology, and mental health. The global telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for AMWL to increase its market share by offering a wider range of services and attracting new patient demographics. Timeline: Ongoing.
• Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, clinics, and physician groups can enable AMWL to integrate its telehealth platform into existing healthcare systems. This can lead to increased adoption of AMWL's services and a broader reach to patients. The market for healthcare partnerships is expanding as healthcare providers seek to enhance their digital capabilities. Timeline: Ongoing.
• Development of Remote Patient Monitoring Solutions: Investing in remote patient monitoring (RPM) technologies can enable AMWL to provide continuous care and monitoring for patients with chronic conditions. The RPM market is projected to grow significantly, driven by the increasing prevalence of chronic diseases and the need for cost-effective healthcare solutions. AMWL can leverage its telehealth platform to offer RPM services and improve patient outcomes. Timeline: Ongoing.
• International Expansion: Expanding its telehealth services to international markets can provide AMWL with access to new patient populations and revenue streams. The global telehealth market is growing rapidly, particularly in developing countries with limited access to healthcare. AMWL can leverage its expertise and technology to establish a presence in international markets and capitalize on the growing demand for telehealth services. Timeline: 2027-2030.
• Integration of Artificial Intelligence (AI): Integrating AI technologies into its telehealth platform can enable AMWL to improve the efficiency and effectiveness of its services. AI can be used for tasks such as automated triage, personalized treatment recommendations, and predictive analytics. The AI in healthcare market is growing rapidly, driven by the increasing availability of healthcare data and the potential for AI to improve patient outcomes and reduce costs. Timeline: Ongoing.

What Are AMWL's Competitive Advantages?

• Established telehealth platform with a wide range of services.
• Extensive network of healthcare providers and partners.
• Proprietary technology and software solutions.
• Brand recognition and reputation in the telehealth market.

What Does AMWL Do?

American Well Corporation, now known as Amwell, was founded in 2006 and is headquartered in Boston, Massachusetts. The company operates as a telehealth software provider, enabling the digital delivery of healthcare services. Amwell's platform offers a wide array of services, including urgent care, scheduled visits, acute behavioral health, telestroke, pediatrics, retail health, school health, and home settings. Its application supports various medical needs, such as urgent care, pediatrics, therapy, menopause nutrition, end-stage renal disease and dialysis, dermatology care, behavioral health therapy, and musculoskeletal care. Beyond its software platform, Amwell provides telemedicine equipment, including telemedicine carts, peripherals, Tyto care devices, TV kits, tablets, and kiosks. This comprehensive approach allows healthcare providers to integrate telehealth solutions seamlessly into their existing practices. Amwell's services cater to both individual patients seeking convenient access to healthcare and healthcare organizations aiming to expand their reach and improve patient outcomes. The company's evolution has been marked by a focus on innovation and expansion of its telehealth offerings to meet the growing demand for remote healthcare solutions.

What Products and Services Does AMWL Offer?

• Provides a telehealth software platform for digital healthcare delivery.
• Offers urgent care services via telehealth.
• Facilitates scheduled virtual visits with healthcare providers.
• Delivers acute behavioral health services remotely.
• Supports telestroke consultations and care.
• Offers pediatric telehealth services.
• Provides telemedicine equipment, including carts and peripherals.

How Does AMWL Make Money?

• Generates revenue through subscription fees from healthcare providers using its platform.
• Earns revenue from per-visit fees for telehealth consultations.
• Sells telemedicine equipment, such as carts and peripherals.
• Forms partnerships with healthcare organizations to integrate its telehealth solutions.

What Industry Does AMWL Operate In?

American Well Corporation operates within the rapidly expanding telehealth market. The industry is driven by increasing demand for remote healthcare services, technological advancements, and regulatory changes that support telehealth adoption. The competitive landscape includes established telehealth providers, traditional healthcare organizations, and emerging technology companies. AMWL's position is characterized by its comprehensive telehealth platform and range of services. The telehealth market is projected to continue growing, presenting both opportunities and challenges for AMWL as it navigates the competitive environment and strives for profitability.

Who Are AMWL's Key Customers?

• Hospitals and healthcare systems
• Physician groups and clinics
• Individual patients seeking telehealth services
• Retail health providers
• Schools and educational institutions

Wall Street analysts project American Well Corporation (AMWL) revenue of about $203.1M for fiscal 2026, with EPS near $-2.56. The estimate reflects 5 contributing analysts.

Quarterly Financial Performance: American Well Corporation (AMWL)

Revenue for American Well Corporation (AMWL) came in at $52.0M during Q2 2026, a 5.2% contraction versus the preceding quarter. The company recorded a net loss of $9.9M, with diluted EPS of $-0.59. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, AMWL averaged $-1.19 in diluted EPS.

AMWL Valuation & Market Position

With a $202M market cap, American Well Corporation (AMWL) sits in the micro-cap segment of the market. Relative to its peer group, AMWL's quantitative score of 17/100 is below the peer average of 64/100.

Return on equity for American Well Corporation (AMWL) stands at -35.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -25.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -53.9%, the inverse of the P/E and a quick read on earnings relative to price.

American Well Corporation (AMWL)'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.09 places it in the distress zone, a signal of elevated financial risk.

American Well Corporation (AMWL) has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 16.9% above estimates on average.

Company Profile

American Well Corporation (AMWL) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Boston, US. The company is led by CEO Ido Schoenberg. AMWL has traded publicly since 2020.

AMWL Financials

AMWL Latest News

AMWL Analyst Consensus

AMWL MoonshotScore

American Well Corporation (AMWL) Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources